3627 results for «439»

Filter By

3627 results

Complex anatomical features

09 Feb 2025 – From PCR Tokyo Valves 2025

Dive into a captivating session that explores complex anatomical features in interventional cardiology. Discover dynamic improvements in tricuspid valve coaptation and regurgitation post-TAVI, the overlooked threat of aortic stenosis hidden by mitral stenosis, marked improvement in left ventricular function after simultaneous TAVI and M-TEER, recognition of...

Complex anatomical features

Challenging TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...

Challenging TAVI

TAV-in-SAV - Part 2

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...

TAV-in-SAV - Part 2

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?